By CHHS Extern Mike Rovetto A few weeks ago, the Supreme Court released its decision in Van Buren v. United States, and the implications this case has for nearly every business and employer in the country could be potentially staggering. Before going into the implications of the case, a brief introduction is warranted. A more […]
About CHHS Research Assistants & Externs
This author has yet to write their bio.
Meanwhile lets just say that we are proud CHHS Research Assistants & Externs contributed a whooping 26 entries.
By CHHS Extern Mike Rovetto A few weeks ago, multiple news agencies covered a memo President Biden’s administration released calling on private business entities to do more against the threat of ransomware and to “better understand [their] critical role”. While the President’s Executive Order is a good first step in fixing the nation’s cybersecurity problem, […]
By CHHS Extern Nicole Fullem Due to the COVID-19 pandemic healthcare systems were forced to move to a more remote environment and required to adopt telehealth services to bring care to patients. The Department of Health and Human Services (HHS) defines telehealth as “the use of electronic information and telecommunications technologies to support and promote […]
By CHHS Extern Emma Barbato Ransomware attacks on healthcare organizations were up 50% in the third quarter of 2020. Since 2016, ransomware attacks on healthcare organizations has cost the healthcare system around 157 million dollars. Because many ransomware attacks count as Health Insurance Portability and Accountability Act (HIPAA) violations, all of this leads to a […]
On August 23, 2020, the US-FDA issued an Emergency Use Authorization (“EUA”) allowing the off-label use of convalescent plasma to treat COVID-19, having concluded that the totality of evidence supported this use. An EUA allows for use of an unapproved therapeutic product by clinicians when needed during public health emergencies. The FDA granted the EUA based […]
Scientists began to investigate Tocilizumab in clinical trials as a possible therapy for COVID-19 because of the drug’s potent anti-inflammatory properties. Tocilizumab, a monoclonal antibody drug manufactured by Hoffman-La Roche, is marketed in the US as Actrema® and is approved for treating arthritis. Tocilizumab effectively treats arthritis by reducing the progression of inflammation in the […]
Vaccination against COVID-19 aims to produce an initial immune response to enable the body to quickly respond to attack and destroy SARS-CoV-2 whenever the vaccinated individual is later infected with the virus. All vaccines aim to expose the body to an agent, called an antigen, to provoke an initial immune response. In the initial immune […]
By CHHS Extern Arsanious Hanna Over the course of the last decade, the United States has been embroiled in a transnational cybersecurity warfare. Washington’s concerns with America’s cybersecurity infrastructure and integrity is in response to years of intelligence agency whistleblowers and cyber hacks. Whistleblowers such as former Army Intelligence Analyst Chelsea Manning, and former NSA […]
CORTICOSTEROID HORMONES AND COVID-19 Introduction. The corticosteroid hormone drugs Dexamethasone and Methylprednisolone have both been successfully used to treat COVID-19 patients. Dexamethasone, approved by the FDA in 1958, is marketed for treating severe or incapacitating allergic conditions. Methylprednisolone, approved by the FDA in 1959, is marketed for treating severe allergic conditions and some types of […]
By CHHS Extern Carly Yost Public health jargon, previously only known by professionals in the field, is now a part of most people’s everyday vernacular. Due to the global pandemic caused by the emergence of COVID-19, contact tracing is among those previously unknown terms that are now a part of everyone’s daily lives. Several large […]
The University of Maryland Center for Health and Homeland Security (CHHS) is a non-profit consulting group and academic center committed to maximizing organizational resilience before, during and after an emergency event.
500 W. Baltimore St
Baltimore, MD 21201
(410) 706-2726 (Fax)